Cytek Biosciences, Inc.
CTKB· Nasdaq
Cytek Biosciences, Inc.
- Last sale
- Oct 1, 2026 · -2.68%
- Market cap
- $753.90M
- 129.98M shares
- Filings
- 461
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $201,493,000 | reported | |
| FY 2024 | 2024-12-31 | $200,453,000 | reported | |
| FY 2023 | 2023-12-31 | $193,015,000 | reported | |
| FY 2022 | 2022-12-31 | $164,036,000 | reported | |
| FY 2021 | 2021-12-31 | $127,950,000 | reported | |
| FY 2020 | 2020-12-31 | $92,839,000 | reported |
Cytek Biosciences, Inc. · CIK 1831915 · Engraved from SEC EDGAR
